AHA and ACC defend risk assessment tool

The American Heart Association and the American College of Cardiology are responding to concerns about a new risk calculator designed to assess which patients should take cholesterol-lowering statin drugs. Harvard professors Dr. Paul Ridker and Dr. Nancy Cook said the tool has serious flaws and significantly overestimates a patient's risk of heart attack and stroke. Officials at the ACC and AHA defended the tool, saying Ridker and Cook's analysis of the calculator was based on three studies whose participants were in better health and younger than average. The PCNA has endorsed the new AHA/ACC guidelines.

View Full Article in:

Clinical Endocrinology News · HealthDay News · Los Angeles Times (tiered subscription model) · New York Times (tiered subscription model), The · MedPage Today (free registration) · Medscape (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Claims Director
PacificSource
Springfield, OR
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA